Cancer Metastasis: Building a Framework
Tài liệu tham khảo
Abbott, 2006, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci., 7, 41, 10.1038/nrn1824
Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100
Al-Mehdi, 2000, Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis, Nat. Med., 6, 100, 10.1038/71429
Alitalo, 2005, Lymphangiogenesis in development and human disease, Nature, 438, 946, 10.1038/nature04480
Allinen, 2004, Molecular characterization of the tumor microenvironment in breast cancer, Cancer Cell, 6, 17, 10.1016/j.ccr.2004.06.010
Bao, 2004, Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, 5, 329, 10.1016/S1535-6108(04)00081-9
Bartkova, 2005, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, 434, 864, 10.1038/nature03482
Baylin, 2006, Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?, Nat. Rev. Cancer, 6, 107, 10.1038/nrc1799
Beachy, 2004, Tissue repair and stem cell renewal in carcinogenesis, Nature, 432, 324, 10.1038/nature03100
Bernards, 2002, A progression puzzle, Nature, 418, 823, 10.1038/418823a
Bhowmick, 2004, TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia, Science, 303, 848, 10.1126/science.1090922
Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730
Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658
Braun, 2005, A pooled analysis of bone marrow micrometastasis in breast cancer, N. Engl. J. Med., 353, 793, 10.1056/NEJMoa050434
Brodeur, 2003, Neuroblastoma: biological insights into a clinical enigma, Nat. Rev. Cancer, 3, 203, 10.1038/nrc1014
Brown, 2004, Metadherin, a cell surface protein in breast tumors that mediates lung metastasis, Cancer Cell, 5, 365, 10.1016/S1535-6108(04)00079-0
Cavallaro, 2004, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nat. Rev. Cancer, 4, 118, 10.1038/nrc1276
Chambers, 2001, CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy, Annu. Rev. Immunol., 19, 565, 10.1146/annurev.immunol.19.1.565
Chambers, 2002, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer, 2, 563, 10.1038/nrc865
Chang, 2004, Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds, PLoS Biol., 2, E7, 10.1371/journal.pbio.0020007
Chi, 2006, Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers, PLoS Med., 3, e47, 10.1371/journal.pmed.0030047
Clark, 2000, Genomic analysis of metastasis reveals an essential role for RhoC, Nature, 406, 532, 10.1038/35020106
Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007
Condeelis, 2003, Intravital imaging of cell movement in tumours, Nat. Rev. Cancer, 3, 921, 10.1038/nrc1231
Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100
Criscuoli, 2005, Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability, Blood, 105, 1508, 10.1182/blood-2004-06-2246
Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6
de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat. Rev. Cancer, 6, 24, 10.1038/nrc1782
Douma, 2004, Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB, Nature, 430, 1034, 10.1038/nature02765
Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev. Cancer, 2, 161, 10.1038/nrc745
Erler, 2006, Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, 440, 1222, 10.1038/nature04695
Feinberg, 2006, The epigenetic progenitor origin of human cancer, Nat. Rev. Genet., 7, 21, 10.1038/nrg1748
Felding-Habermann, 2001, Integrin activation controls metastasis in human breast cancer, Proc. Natl. Acad. Sci. USA, 98, 1853, 10.1073/pnas.98.4.1853
Fidler, 2003, The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited, Nat. Rev. Cancer, 3, 453, 10.1038/nrc1098
Friedl, 2003, Tumour-cell invasion and migration: diversity and escape mechanisms, Nat. Rev. Cancer, 3, 362, 10.1038/nrc1075
Gorelik, 2002, Transforming growth factor-beta in T-cell biology, Nat. Rev. Immunol., 2, 46, 10.1038/nri704
Gorgoulis, 2005, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature, 434, 907, 10.1038/nature03485
Guo, 2004, Integrin signalling during tumour progression, Nat. Rev. Mol. Cell Biol., 5, 816, 10.1038/nrm1490
Gupta, 2005, The melanocyte differentiation program predisposes to metastasis after neoplastic transformation, Nat. Genet., 37, 1047, 10.1038/ng1634
Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9
Harada, 2003, Control of osteoblast function and regulation of bone mass, Nature, 423, 349, 10.1038/nature01660
Harris, 2002, Hypoxia–a key regulatory factor in tumour growth, Nat. Rev. Cancer, 2, 38, 10.1038/nrc704
Hernando, 2004, Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control, Nature, 430, 797, 10.1038/nature02820
Hill, 2005, Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis, Cell, 123, 1001, 10.1016/j.cell.2005.09.030
Hiratsuka, 2002, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, 2, 289, 10.1016/S1535-6108(02)00153-8
Hu, 2005, Distinct epigenetic changes in the stromal cells of breast cancers, Nat. Genet., 37, 899, 10.1038/ng1596
Hussain, 2003, Radical causes of cancer, Nat. Rev. Cancer, 3, 276, 10.1038/nrc1046
Jones, 2006, Regulation of cancer cell migration and bone metastasis by RANKL, Nature, 440, 692, 10.1038/nature04524
Kalluri, 2006, Fibroblasts in cancer, Nat. Rev. Cancer, 6, 392, 10.1038/nrc1877
Kang, 2003, A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, 3, 537, 10.1016/S1535-6108(03)00132-6
Kang, 2005, Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway, Proc. Natl. Acad. Sci. USA, 102, 13909, 10.1073/pnas.0506517102
Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186
Karhadkar, 2004, Hedgehog signalling in prostate regeneration, neoplasia and metastasis, Nature, 431, 707, 10.1038/nature02962
Karin, 2006, Nuclear factor-kappaB in cancer development and progression, Nature, 441, 431, 10.1038/nature04870
Khanna, 2004, The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis, Nat. Med., 10, 182, 10.1038/nm982
Kim, 2006, Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene, Cell, 125, 1269, 10.1016/j.cell.2006.06.008
Klein, 2002, Combined transcriptome and genome analysis of single micrometastatic cells, Nat. Biotechnol., 20, 387, 10.1038/nbt0402-387
Klezovitch, 2004, Hepsin promotes prostate cancer progression and metastasis, Cancer Cell, 6, 185, 10.1016/j.ccr.2004.07.008
Kurose, 2002, Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas, Nat. Genet., 32, 355, 10.1038/ng1013
Langowski, 2006, IL-23 promotes tumour incidence and growth, Nature, 442, 461, 10.1038/nature04808
Liotta, 2001, The microenvironment of the tumour-host interface, Nature, 411, 375, 10.1038/35077241
Logothetis, 2005, Osteoblasts in prostate cancer metastasis to bone, Nat. Rev. Cancer, 5, 21, 10.1038/nrc1528
Luo, 2004, Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression, Cancer Cell, 6, 297, 10.1016/j.ccr.2004.08.012
Lynch, 2005, MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL, Cancer Cell, 7, 485, 10.1016/j.ccr.2005.04.013
Maser, 2002, Connecting chromosomes, crisis, and cancer, Science, 297, 565, 10.1126/science.297.5581.565
Mehlen, 2006, Metastasis: a question of life or death, Nat. Rev. Cancer, 6, 449, 10.1038/nrc1886
Minn, 2005, Genes that mediate breast cancer metastasis to lung, Nature, 436, 518, 10.1038/nature03799
Minn, 2005, Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors, J. Clin. Invest., 115, 44, 10.1172/JCI22320
Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016
Mundy, 2002, Metastasis to bone: causes, consequences and therapeutic opportunities, Nat. Rev. Cancer, 2, 584, 10.1038/nrc867
Nash, 2002, Platelets and cancer, Lancet Oncol., 3, 425, 10.1016/S1470-2045(02)00789-1
Norton, 2006, Is cancer a disease of self-seeding?, Nat. Med., 12, 875, 10.1038/nm0806-875
Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034
Overall, 2006, Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy, Nat. Rev. Cancer, 6, 227, 10.1038/nrc1821
Paget, 1889, The distribution of secondary growths in cancer of the breast, Lancet, 1, 571, 10.1016/S0140-6736(00)49915-0
Pantel, 2004, Dissecting the metastatic cascade, Nat. Rev. Cancer, 4, 448, 10.1038/nrc1370
Pardal, 2003, Applying the principles of stem-cell biology to cancer, Nat. Rev. Cancer, 3, 895, 10.1038/nrc1232
Park, 2005, Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1, Nat. Genet., 37, 1055, 10.1038/ng1635
Paszek, 2005, Tensional homeostasis and the malignant phenotype, Cancer Cell, 8, 241, 10.1016/j.ccr.2005.08.010
Pennacchietti, 2003, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, 3, 347, 10.1016/S1535-6108(03)00085-0
Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093
Puc, 2005, Lack of PTEN sequesters CHK1 and initiates genetic instability, Cancer Cell, 7, 193, 10.1016/j.ccr.2005.01.009
Radtke, 2005, Self-renewal and cancer of the gut: two sides of a coin, Science, 307, 1904, 10.1126/science.1104815
Ruiter, 2001, Tumour metastasis: is tissue an issue?, Lancet Oncol., 2, 109, 10.1016/S1470-2045(00)00229-1
Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187
Siegel, 2003, Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis, Proc. Natl. Acad. Sci. USA, 100, 8430, 10.1073/pnas.0932636100
Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128
Solakoglu, 2002, Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors, Proc. Natl. Acad. Sci. USA, 99, 2246, 10.1073/pnas.042372199
Staller, 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature, 425, 307, 10.1038/nature01874
Stupack, 2006, Potentiation of neuroblastoma metastasis by loss of caspase-8, Nature, 439, 95, 10.1038/nature04323
Takeda, 2001, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, Nat. Med., 7, 94, 10.1038/83416
Tarin, 1984, Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts, Cancer Res., 44, 3584
Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005
Varambally, 2002, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, 419, 624, 10.1038/nature01075
Wang, 2004, Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis, J. Cell Biol., 164, 935, 10.1083/jcb.200309112
Weigelt, 2005, Breast cancer metastasis: markers and models, Nat. Rev. Cancer, 5, 591, 10.1038/nrc1670
Weis, 2005, Pathophysiological consequences of VEGF-induced vascular permeability, Nature, 437, 497, 10.1038/nature03987
Wicki, 2006, Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton, Cancer Cell, 9, 261, 10.1016/j.ccr.2006.03.010
Yang, 2004, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell, 117, 927, 10.1016/j.cell.2004.06.006
Ye, 2003, Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning, Nat. Med., 9, 416, 10.1038/nm843
Yilmaz, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells, Nature, 441, 475, 10.1038/nature04703
Yin, 1999, TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development, J. Clin. Invest., 103, 197, 10.1172/JCI3523
Zou, 2005, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nat. Rev. Cancer, 5, 263, 10.1038/nrc1586